ABSTRACT
Prenatal exposure to glucocorticoids (GC) is a central topic of interest in medicine since GCs are essential for the maturation of fetal organs and intrauterine growth. Synthetic glucocorticoids, which are used in obstetric practice, exert beneficial effects on the fetus, but have also been reported to lead to intrauterine growth retardation (IUGR). In this study, a model of growth restriction in mice was established through maternal administration of dexamethasone during late gestation. We hypothesised that GC overexposure may adversely affect placental angiogenesis and fetal and placental growth. Female BALB/c mice were randomly assigned to control or dexamethasone treatment, either left to give birth or euthanised on days 15, 16, 17 and 18 of gestation followed by collection of maternal and fetal tissue. The IUGR rate increased to 100% in the dexamethasone group (8 mg/kg body weight on gestational days 14 and 15) and pups had clinical features of symmetrical IUGR at birth. Dexamethasone administration significantly decreased maternal body weight gain and serum corticosterone levels. Moreover, prenatal dexamethasone treatment not only induced fetal growth retardation but also decreased placental weight. In IUGR placentas, VEGFA protein levels and mRNA expression of VEGF receptors were reduced and NOS activity was lower. Maternal dexamethasone administration also reduced placental expression of the GC receptor, αGR. We demonstrated that maternal dexamethasone administration causes fetal and placental growth restriction. Furthermore, we propose that the growth retardation induced by prenatal GC overexposure may be caused, at least partially, by an altered placental angiogenic profile.
Subject(s)
Dexamethasone , Fetal Growth Retardation/metabolism , Placenta/metabolism , Placentation , Vascular Endothelial Growth Factor A/metabolism , Animals , Disease Models, Animal , Down-Regulation , Female , Fetal Growth Retardation/chemically induced , Fetal Growth Retardation/physiopathology , Gene Expression Regulation, Developmental , Gestational Age , Mice, Inbred BALB C , Nitric Oxide/metabolism , Nitric Oxide Synthase/metabolism , Placenta/physiopathology , Pregnancy , Receptors, Glucocorticoid/metabolism , Receptors, Vascular Endothelial Growth Factor/metabolism , Signal Transduction , Vascular Endothelial Growth Factor A/geneticsABSTRACT
Bioethanol for use in vehicles is becoming a substantial part of global energy infrastructure because it is renewable and some emissions are reduced. Carbon monoxide (CO) emissions and total hydrocarbons (THC) are reduced, but there is still controversy regarding emissions of nitrogen oxides (NOx), aldehydes, and ethanol; this may be a concern because all these compounds are precursors of ozone and secondary organic aerosol (SOA). The amount of emissions depends on the ethanol content, but it also may depend on the engine quality and ethanol origin. Thus, a photochemical chamber was used to study secondary gas and aerosol formation from two flex-fueled vehicles using different ethanol blends in gasoline. One vehicle and the fuel used were made in the United States, and the others were made in Brazil. Primary emissions of THC, CO, carbon dioxide (CO2), and nonmethane hydrocarbons (NMHC) from both vehicles decreased as the amount of ethanol in gasoline increased. NOx emissions in the U.S. and Brazilian cars decreased with ethanol content. However, emissions of THC, CO, and NOx from the Brazilian car were markedly higher than those from the U.S. car, showing high variability between vehicle technologies. In the Brazilian car, formation of secondary nitrogen dioxide (NO2) and ozone (O3) was lower for higher ethanol content in the fuel. In the U.S. car, NO2 and O3 had a small increase. Secondary particle (particulate matter [PM]) formation in the chamber decreased for both vehicles as the fraction of ethanol in fuel increased, consistent with previous studies. Secondary to primary PM ratios for pure gasoline is 11, also consistent with previous studies. In addition, the time required to form secondary PM is longer for higher ethanol blends. These results indicate that using higher ethanol blends may have a positive impact on air quality. IMPLICATIONS: The use of bioethanol can significantly reduce petroleum use and greenhouse gas emissions worldwide. Given the extent of its use, it is important to understand its effect on urban pollution. There is a controversy on whether there is a reduction or increase in PM emission when using ethanol blends. Primary emissions of THC, CO, CO2, NOx, and NMHC for both cars decreased as the fraction of ethanol in gasoline increased. Using a photochemical chamber, the authors have found a decrease in the formation of secondary particles and the time required to form secondary PM is longer when using higher ethanol blends.
Subject(s)
Air Pollutants/chemistry , Biofuels/analysis , Ethanol/analysis , Vehicle Emissions/analysis , Aerosols , Automobiles , Carbon Dioxide/analysis , Carbon Monoxide/analysis , Gasoline/analysis , Hydrocarbons/analysis , Nitrogen Oxides/analysis , Ozone/chemistry , Particulate Matter/analysisABSTRACT
The endocannabinoid system consists in a family of lipids that binds to and activates cannabinoid receptors. There are two receptors so far described, the cannabinoid receptor 1 (CB1) and 2 (CB2). In the context of pregnancy, the endocannabinoid system was shown participates in different key aspects of reproductive events. B-lymphocytes are pleiotropic cells belonging to the adaptive arm of the immune system. Besides immunoglobulin production, B-lymphocytes were recently shown to be actively involved in antigen presentation as well as cytokine production, thus playing a central role in immunity. In this study we first aimed to characterize the expression of CB1 and CB2 receptors in B cells during pregnancy and then analyze the impact of their activation in term of cytokine production by B cells from pregnant and non-pregnant mice. We observed that the expression of CB1 and CB2 receptors in B-lymphocytes is differentially regulated during pregnancy. While CB2 expression is down regulated CB1 is augmented in B-lymphocytes of pregnant mice. Additionally, the treatment of activated B-lymphocytes with specific CB1 and CB2 agonists, showed a different response in term of cytokine production. Particularly, CB1 against boosted the production of the anti-inflammatory cytokine IL-10 by activated B-lymphocytes from pregnant mice.
Subject(s)
B-Lymphocytes/immunology , Receptor, Cannabinoid, CB1/metabolism , Receptor, Cannabinoid, CB2/metabolism , Animals , Cells, Cultured , Female , Gene Expression Regulation , Humans , Immune Tolerance , Interleukin-10/metabolism , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Pregnancy , Receptor, Cannabinoid, CB1/genetics , Receptor, Cannabinoid, CB2/geneticsABSTRACT
Endocannabinoids are an important family of lipid-signaling molecules that are widely distributed in mammalian tissues and anandamide (AEA) was the first member identified. The uterus contains the highest concentrations of AEA yet discovered in mammalian tissues and this suggests that it might play a role in reproduction. Previous results from our laboratory have shown that AEA modulated NO synthesis in rat placenta. The production of small amounts of nitric oxide regulates various physiological reproductive processes such as implantation, decidualization and myometrial relaxation. But in an inflammatory setting such as sepsis, NO is produced in big amounts and has toxic effects as it is a free radical. The results presented in this study indicate that LPS-induced NO synthesis and tissue damage were mediated by AEA. Decidual LPS-induced NO production was abrogated either by co-incubation with CB1 (AM251) or CB2 (SR144528) antagonists which suggests that both receptors could be mediating this effect. On the other hand, LPS-induced tissue damage and this deleterious effect was partially abrogated by incubating tissue explants with LPS plus CB1 receptor antagonist. Our findings suggest that AEA, probably by increasing NO synthesis, participates in the deleterious effect of LPS in implantation sites. These effects could be involved in pathological reproductive events such as septic abortion.
Subject(s)
Arachidonic Acids/metabolism , Cannabinoid Receptor Modulators/metabolism , Decidua , Endocannabinoids , Lipopolysaccharides/pharmacology , Nitric Oxide/metabolism , Polyunsaturated Alkamides/metabolism , Abortion, Septic/immunology , Abortion, Septic/metabolism , Amidohydrolases/metabolism , Animals , Arachidonic Acids/pharmacology , Cannabinoid Receptor Antagonists , Cells, Cultured , Decidua/drug effects , Decidua/immunology , Decidua/metabolism , Female , Male , Mice , Mice, Inbred BALB C , Nitrates/metabolism , Nitric Oxide Synthase Type II/metabolism , Nitrites/metabolism , Nitrogen/metabolism , Phospholipase D/metabolism , Pregnancy , Receptors, Cannabinoid/metabolismABSTRACT
Twenty-one-day-old Wistar rats were fed a diet containing 0.6% cuprizone for 2 weeks. Studies carried out after withdrawal of cuprizone showed histological evidences of marked demyelination in the corpus callosum. Biochemical studies of isolated myelin showed a marked decrease in myelin proteins, phospholipids, and galactocerebrosides as well as a marked decrease in myelin yield. Treatment of these animals with a single intracranial injection of 350 ng of apotransferrin at the time of withdrawal of cuprizone induced a marked increase in myelin deposition resulting in a significantly improved remyelination, evaluated by histological, immunocytochemical, and biochemical parameters, in comparison to what was observed in spontaneous recovery. Immunocytochemical studies of cryotome sections to analyze developmental parameters of the oligodendroglial cell population at the time of termination of cuprizone and at different times thereafter showed that in the untreated animals, there was a marked increase in the number of NG2-BrdU-positive precursor cells together with a marked decrease in MBP expression at the peak of cuprizone-induced demyelination. As expected, the amount of precursor cells decreased markedly during spontaneous remyelination and was accompanied by an increase in MBP reactivity. In the apotransferrin-treated animals, these phenomena occurred much faster, and remyelination was much more efficient than in the untreated controls. The results of this study suggest that apotransferrin is a very active promyelinating agent which could be important for the treatment of certain demyelinating conditions.
Subject(s)
Apoproteins/therapeutic use , Cuprizone , Demyelinating Diseases/drug therapy , Recovery of Function/drug effects , Regeneration/drug effects , Transferrin/therapeutic use , Analysis of Variance , Animals , Animals, Newborn , Antigens/metabolism , Apoproteins/pharmacology , Brain/pathology , Bromodeoxyuridine/pharmacokinetics , CD11b Antigen/metabolism , Cell Count/methods , Cytoskeletal Proteins/metabolism , Demyelinating Diseases/chemically induced , Demyelinating Diseases/physiopathology , Drug Interactions , Galactolipids/metabolism , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry/methods , Indoles , Myelin Basic Protein/metabolism , Myelin Sheath/drug effects , Myelin Sheath/pathology , Proteoglycans/metabolism , Rats , Rats, Wistar , Regeneration/physiology , Time Factors , Transferrin/pharmacologyABSTRACT
Growth-associated protein-43 (GAP-43) is a phosphoprotein whose expression in neurons is related to the initial establishment and remodeling of neural connections. GAP-43 gene expression is known to be regulated at both the transcriptional and the postranscriptional levels. However, very little is known about the cellular mechanism involved in the degradation of this protein. Ubiquitin (Ub) is well known for its role in targeting cytoplasmic proteins for degradation by the 26S proteasome. The ubiquitin-proteasome system (UPS) consists of a conserved cascade of three enzymatic components that attach Ub covalently to various substrates and control the degradation of protein involved in several important cellular processes. In this study, we investigated the degradation of GAP-43 in transfected NIH 3T3 cells and neuronal cultures. We found that the proteasome inhibitors, lactacystin and MG132 increased the cellular GAP-43 level, leading to the accumulation of polyubiquitinated forms of this protein in transfected cells and that the Ub-proteasome pathway is also involved in the turnover of this protein in neurons. We conclude based on our findings that GAP-43 is a substrate of the UPS.
Subject(s)
Acetylcysteine/analogs & derivatives , GAP-43 Protein/metabolism , Gene Expression Regulation/physiology , Proteasome Endopeptidase Complex/metabolism , Ubiquitin/metabolism , Acetylcysteine/pharmacology , Animals , Blotting, Western/methods , Cell Survival/drug effects , Cells, Cultured , Cerebral Cortex/cytology , Cysteine Proteinase Inhibitors/pharmacology , Dose-Response Relationship, Drug , Embryo, Mammalian , Female , GAP-43 Protein/genetics , Genetic Vectors/physiology , Green Fluorescent Proteins/biosynthesis , Immunohistochemistry/methods , Immunoprecipitation/methods , Leupeptins/pharmacology , Male , Mice , Mutagenesis/physiology , NIH 3T3 Cells , Neurons/drug effects , Neurons/metabolism , Pregnancy , Rats , Rats, Wistar , Transfection/methodsABSTRACT
OBJECTIVE: To examine the relationships among exposure to violence; tobacco, alcohol, and other substance use; depression; church attendance; and the use of violence among very young adolescents. METHODS: An 86-item confidential questionnaire was administered to 722 sixth grade students (mean age = 11.9+/-0.8 years) attending 4 middle schools serving neighborhoods in and around public housing. RESULTS: Boys had a higher mean violence scale score than girls (P < or =.0001), and students living in public housing had higher violence scale scores than other students (P< or =.0001). Self-reported use of violence was significantly associated with exposure to violence (r =.45); age (r =.28); frequency of church attendance (r = -.14); depression (r =.28); the probability of being alive at age 25 (r = -.09); the frequency of use of cigarettes (r =.39), alcohol (r =.37), and multiple substances (r =.38); and interest in a gang (r =.37). When all of these variables were analyzed with multiple linear regression, multiple substance use, exposure to violence, interest in a gang, male gender, cigarette smoking, and depression level accounted for 49.7% of the variation in the use of violence scale. CONCLUSION: Recent multiple substance use and lifetime exposure to violence and victimization were the strongest correlates with the frequency that these youth reported using violence and carrying weapons.
Subject(s)
Adolescent Behavior , Crime Victims , Violence , Adolescent , Child , Crime Victims/psychology , Crime Victims/statistics & numerical data , Depression , Female , Georgia , Humans , Linear Models , Male , Religion , Risk Factors , Socioeconomic Factors , Substance-Related Disorders , Surveys and Questionnaires , Violence/psychology , Violence/statistics & numerical dataABSTRACT
To determine the effect of acute hypercarbia on brain-stem function in preterm neonates, we compared brain-stem auditory evoked responses (BAERs) during 8% CO2 breathing to those elicited during room air breathing in 12 healthy preterm infants during the first week of life. End-tidal CO2 (ETpCO2), respiratory rate and depth were monitored throughout the protocol. Absolute wave latencies and interpeak intervals of the BAERs were analyzed from duplicate trials. During 8% CO2 breathing, ETpCO2, respiratory rate and depth of respiration increased significantly (P < 0.05). The absolute latency of wave V was prolonged (P < 0.025) in the hypercarbic state as compared to baseline. Interpeak interval III-V was also prolonged (P < 0.025). Values of absolute peak latencies I and III were unaffected by the hypercarbic state. These data demonstrate that elevations in pCO2 which elicit ventilatory responses also effect the BAER. The specific effects on ventilatory pattern, peak V latency and interpeak interval III-V indicate brain-stem responsiveness and alterations in the more central components of the auditory pathway. These findings raise important considerations regarding the influence of hypercarbia on brain-stem function in preterm infants and the clinical management of such infants with abnormalities of gas exchange.
Subject(s)
Evoked Potentials, Auditory, Brain Stem , Hypercapnia/physiopathology , Infant, Premature , Administration, Inhalation , Carbon Dioxide/therapeutic use , Humans , Hypercapnia/therapy , Infant, Newborn , Reaction Time , RespirationABSTRACT
The use of perfluorochemical (PFC) liquids to facilitate or support respiration has been under study for several decades. The low surface tension and high respiratory gas solubility of liquid PFC enable adequate oxygenation and carbon dioxide removal at low insufflation pressures relative to gas ventilation in the immature or injured lung. Because liquid ventilation homogeneously inflates the lung and improves V/Q matching it has been studied as a vehicle for delivering biologically active agents to the lung tissues and systemic circulation. More recently, we have shown the utility of highly opaque PFC liquids as a high resolution computed tomographic (HRCT) bronchographic contrast agent either during LV or gas breathing after tracheal instillation of small quantities of PFC. As a result of extensive experimental work in premature animals as well as lung injury models, liquid PFC ventilation has been recently implemented as an investigational therapy for severe respiratory distress in human infants. This manuscript summarizes the physiological principles and applications of LV as well as the results of initial investigational clinical studies in human neonates with severe respiratory distress.
Subject(s)
Fluorocarbons/therapeutic use , Respiratory Tract Diseases/drug therapy , Clinical Trials as Topic , Contrast Media , Humans , Lung Neoplasms/therapy , Pulmonary Surfactants/deficiency , Respiration, Artificial/methods , Therapeutic IrrigationABSTRACT
To evaluate the effect of the physical properties of density and viscosity on airway resistance, three perfluorochemical fluids (PFCs) were used: FC-75, Liquivent, and APF-140. Using two different endotracheal tubes (ETT) (3.0mm ID and 4.0mm internal diameter (ID)), the three fluids were studied at steady state flow conditions over a range that approximated peak flow required for liquid ventilation of neonatal lambs (0.005-0.02 l/sec). The slope of airway resistance (Raw)-flow curves and absolute values of Raw for the 3 PFC liquids were higher for the 3.0 ETT compared to the 4.0 ETT. The 3.0 ETT demonstrated resistance changes that were dependent on flow, density and viscosity. The 4.0 ETT showed a resistance-flow relationship that was relatively less dependent on flow, density and viscosity.
Subject(s)
Airway Resistance/drug effects , Fluorocarbons/pharmacology , Intubation, Intratracheal/methods , Animals , Animals, Newborn , Chemical Phenomena , Chemistry, Physical , Intubation, Intratracheal/instrumentation , SheepABSTRACT
The use of neat perfluorochemical liquid (PFC) as an alternative respiratory medium has gained increasing attention for assessment and treatment of the immature or injured lung. In vitro and in vivo plain film and computed tomographic (CT) studies were performed on small and large animals to evaluate the use of perfluorooctylbromide (perflubron) as a bronchographic contrast agent and to quantitate the distribution and elimination of this fluid from the lung following total liquid ventilation or during gas breathing after tracheal instillation of small quantities of this liquid. The results demonstrate the utility of a highly radiopaque PFC liquid in combination with diagnostic imaging techniques to visualize small airways anatomy, identify regional and gravity dependent differences in distribution/elimination of the fluid, ventilation, and track PFC liquid following therapeutic application.
Subject(s)
Fluorocarbons , Lung Diseases/diagnostic imaging , Animals , Contrast Media , Evaluation Studies as Topic , Hydrocarbons, Brominated , In Vitro Techniques , Rats , Sheep , Tomography, X-Ray ComputedABSTRACT
The present study was designed to evaluate the effect of a perfluorocarbon erythrocyte substitute on hemodynamics in the newborn lamb. Isovolumic double volume exchange transfusions were performed with perfluorocarbon emulsion (FC-43) on lambs who were ventilated to maintain normal acid base status. Hematocrit, fluorocrit, viscosity, arterial gas tensions, mean arterial pressure, and heart rate were determined before (control) and after (exchange) exchange transfusion. A radiolabeled microsphere technique was used and cardiac output, organ blood flow, organ vascular resistance, and oxygen delivery were calculated. As the hematocrit and viscosity decreased and the fluorocrit increased, there was a significant increase in PaO2 as well as a significant decrease in A-a gradient and oxygen content. There was no significant change in the acid-base status or the hemodynamic profile (heart rate, stroke volume, cardiac output, and mean arterial pressure). Blood flow to the heart and brain showed a significant increase, whereas flow to the cortex of the kidney showed a significant decrease. There was no significant change in flow to the gastrointestinal tract. Organ vascular resistance in the brain significantly decreased, increased in the kidney, and showed no significant change in the heart and gastrointestinal tract. Oxygen delivery significantly decreased in all organs except the heart. These data suggest that perfluorocarbon emulsions can acutely maintain hemodynamic stability in the newborn lamb and that the intrinsic properties of perfluorocarbons allow for the preservation of adequate oxygenation and acid-base status.
Subject(s)
Animals, Newborn/physiology , Exchange Transfusion, Whole Blood/standards , Fluorocarbons/therapeutic use , Hemodynamics/drug effects , Viscera/drug effects , Animals , Blood Gas Analysis , Blood Viscosity/drug effects , Carbon Radioisotopes , Drug Evaluation, Preclinical , Exchange Transfusion, Whole Blood/methods , Fluorocarbons/administration & dosage , Fluorocarbons/pharmacology , Hematocrit , Humans , Microspheres , Oxygen Consumption/drug effects , Sheep , Viscera/blood supplyABSTRACT
In the clinical setting, nasal cannulas are frequently used to deliver supplemental oxygen to neonates and are not believed to affect the general respiratory status. In contrast, it was hypothesized that clinical changes associated with nasal cannula gas flow may be related in part to the generation of positive end-distending pressure. To test this hypothesis, alterations in esophageal pressure were quantified as an indication of end-distending pressure and thoracoabdominal motion was quantified as an indication of breathing patterns in 13 preterm infants at gas flow levels of 0.5, 1, and 2 L/min delivered by nasal cannula with an outer diameter of either 0.2 or 0.3 cm. Changes in esophageal pressure were assessed by esophageal balloon manometry. Ventilatory patterns were assessed from thoracoabdominal motion by using respiratory inductive plethysmography. Thoracoabdominal motion was quantitated as a phase angle (theta); larger values represent greater asynchrony. The 0.2-cm nasal cannula did not deliver pressure or alter thoracoabdominal motion at any flow. In contrast, the 0.3-cm nasal cannula delivered positive end-distending pressure as a function of increasing levels of gas flow (r = .92) and reduced thoracoabdominal motion asynchrony. The mean pressure generated at 2 L/min was 9.8 cm H2O. These data demonstrate that nasal cannula gas flow can deliver positive end-distending pressure to infants and significantly alter their breathing strategy. This finding raises important concerns about the indiscriminate therapeutic use, size selection, and safety of nasal cannulas for the routine delivery of oxygen in preterm infants.
Subject(s)
Esophagus/physiology , Infant, Premature , Intubation/adverse effects , Nose , Oxygen Inhalation Therapy/adverse effects , Pressure , Respiration/physiology , Equipment Design/standards , Evaluation Studies as Topic , Humans , Infant, Newborn , Intubation/instrumentation , Manometry , Oxygen Inhalation Therapy/instrumentation , Plethysmography, Impedance , Pulmonary Gas Exchange , Respiratory MechanicsABSTRACT
To determine whether changes in lung volume may be responsible for the clinical improvement in preterm infants given exogenous surfactant, we measured functional residual capacity (FRC), lung mechanics, and partial pressure of oxygen in seven ventilated neonates (birth weight 1080 +/- 361 gm (mean +/- SD); gestational age 28.3 +/- 2.6 weeks) less than 9 hours of age who had findings typical of hyaline membrane disease. All patients received 100 mg/kg calf lung surfactant extract. FRC was measured by a closed-circuit helium-dilution technique, and lung mechanics were determined by least mean squares analysis. FRC increased in all patients (range 56% to 330%; p less than 0.03). Dynamic lung compliance and total airway conductance did not change. Mean +/- SEM specific lung compliance (dynamic lung compliance/FRC) decreased 55.93% +/- 4.27% (p less than 0.02) and mean specific conductance (total airway conductance/FRC) decreased 45.91% +/- 9.74% (p less than 0.009). Mean alveolar/arterial partial pressure of oxygen ratio decreased 51.0% +/- 8.67% (p less than 0.01). These data indicate that the immediate improvement in oxygenation after surfactant administration is related to increased lung volumes. The decrease in specific lung compliance and specific airway conductance is suggestive of increased distention rather than recruitment of functional alveoli.
Subject(s)
Functional Residual Capacity , Hyaline Membrane Disease/therapy , Infant, Premature, Diseases/therapy , Pulmonary Surfactants/therapeutic use , Humans , Hyaline Membrane Disease/physiopathology , Infant, Newborn , Infant, Premature, Diseases/physiopathology , Lung Compliance , Pulmonary Gas Exchange/physiologyABSTRACT
This report details the application of liquid perfluorochemical ventilation for investigational therapy in three human preterm neonates (gestational ages 28, 24, and 23 weeks) in whom conventional therapies for severe respiratory distress had failed. Liquid ventilation was performed without difficulty in each infant for two 3- to 5-minute cycles by means of gravity-assisted technique. Marked improvement in lung distensibility, without a change in cardiovascular status, occurred in all three infants after liquid ventilation; oxygenation improved in two. All infants died within 19 hours of liquid ventilation, and there was no evidence of retained perfluorochemical fluid in the lungs or pleural space. Death was probably related to the severity of lung disease before the initiation of liquid ventilation. This satisfactory initial outcome shows the feasibility and potential of this treatment of pulmonary dysfunction in the preterm neonate.
Subject(s)
Fluorocarbons/administration & dosage , Infant, Premature , Oxygen Inhalation Therapy/methods , Oxygen/administration & dosage , Respiration, Artificial/methods , Respiratory Distress Syndrome, Newborn/therapy , Airway Resistance , Blood Pressure , Carbon Dioxide/blood , Heart Rate , Hemoglobins/analysis , Humans , Infant, Newborn , Intubation, Intratracheal , Lung Compliance , Oxygen/blood , Tidal Volume , Time FactorsABSTRACT
Thoracoabdominal asynchrony (TAA) has long been thought clinically useful in the assessment of airflow obstruction (AO) in infants. To test the hypothesis that the measurement of TAA is useful in the assessment of lung mechanics in infants with AO, we have used respiratory inductive plethysmography (RIP) to quantity TAA. We compared changes in TAA to changes in lung mechanics before and after aerosolized bronchodilator (BD) administration in 13 infants. Abdominal wall (AB) and rib cage (RC) motion were displayed on an X-Y recorder in a Lissajous figure. Asynchrony between RC and AB motion was quantified by comparing the width m of the Lissajous figure (difference between AB inspiratory and expiratory positions) at mid-RC excursion with the total AB excursion at its extremes (s). Phase angle phi ws computed as sin phi = m/s (or phi = 180 degrees - mu, where sin mu = m/s for phase angles greater than 90 degrees) and was taken as a measure of TAA. Lung resistance RL and elastance EL were calculated from esophageal pressure (Pes), mouth pressure, tidal volume, and tidal flow. All infants displayed TAA at baseline. After BD administration, TAA decreased in those infants in whom RL decreased. The percentage decrease in the phase angle from baseline after BD administration was significantly correlated with the decrease in peak-to-peak Pes (delta Pes) and the percentage decrease in RL and EL. We conclude that AO in infants leads to TAA through altered pleural pressure swings acting on the compliant chest wall. Changes in lung mechanics induced by bronchodilators are reflected in changes in TAA.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Abdominal Muscles/physiopathology , Airway Obstruction/physiopathology , Respiratory Mechanics/physiology , Abdominal Muscles/drug effects , Aerosols , Airway Obstruction/diagnosis , Airway Obstruction/drug therapy , Bronchiolitis, Viral/drug therapy , Bronchiolitis, Viral/physiopathology , Bronchodilator Agents/therapeutic use , Bronchopulmonary Dysplasia/drug therapy , Bronchopulmonary Dysplasia/physiopathology , Humans , Infant , Infant, Newborn , Plethysmography/methods , Respiratory Mechanics/drug effectsABSTRACT
Response to bronchodilator (BD) and chest physical therapy (CPT) was evaluated in newly diagnosed infants with cystic fibrosis (n = 13; age, 6.9 +/- 1.5 SE months) who were asymptomatic for lung disease at the time of the study. Lung function was assessed from the mechanics and energetics of breathing prior to and following combined BD and CPT. After therapy, respiratory rate, tidal volume, minute ventilation, and pulmonary compliance were not statistically different from values under baseline conditions. In contrast, there was a significant decrease in pulmonary resistance (-34%; P less than 0.05) and the resistive work of breathing (-26%; P less than 0.05) following the combined treatment. The effect of combined BD and CPT in decreasing the resistive respiratory load may be related to relief of subclinical bronchospasm, reduction in mucosal edema, and mobilization of mucous secretions.
Subject(s)
Bronchodilator Agents/therapeutic use , Cystic Fibrosis/therapy , Respiratory Therapy , Work of Breathing , Combined Modality Therapy , Cystic Fibrosis/physiopathology , Drainage , Humans , Infant , Percussion , Posture , VibrationABSTRACT
The mechanics and energetics of breathing were studied in preterm infants with bronchopulmonary dysplasia while spontaneously breathing control gas and helium-oxygen (Heliox) gas mixtures. During Heliox breathing, there was a significant decrease in pulmonary resistance, resistive work of breathing, and mechanical power of breathing, whereas ventilation remained unchanged. Breathing a lower density gas mixture (Heliox) may have therapeutic value by decreasing the demands on the respiratory muscles and the caloric requirements for breathing. Therefore, this modality may reduce potential respiratory muscle fatigue and avail additional calories for growth and recovery in the preterm infant with bronchopulmonary dysplasia.